Immune Responses Induced by Replication-Defective Adenovirus Expressing the C-Terminal Portion of the Mycoplasma hyopneumoniae P97 Adhesin

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinical and Vaccine Immunology

• Publication date

  2007-04-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/CVI.00415-06PMID 17409219PMCID PMC1951074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mucosal vaccines: the promise and the challenge

  2006cited by this paper
• Cytokine expression in porcine lungs experimentally infected with Mycoplasma hyopneumoniae.

  2006cited by this paper
• Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages.

  2006cited by this paper
• Identification and immunological characterization of conserved Mycoplasma hyopneumoniae lipoproteins Mhp378 and Mhp651.

  2006cited by this paper
• Two Domains within the Mycoplasma hyopneumoniae Cilium Adhesin Bind Heparin

  2006cited by this paper
• A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice.

  2006cited by this paper
• Evaluation of the immunogenicity of the P97R1 adhesin of Mycoplasma hyopneumoniae as a mucosal vaccine in mice.

  2006cited by this paper
• Posture In The Picture: On The Relevance Of Postural Control In Children With Developmental Motor Disorders

  2005cited by this paper
• Epitope mapping of Mycoplasma hyopneumoniae using phage displayed peptide libraries and the immune responses of the selected phagotopes.

  2005cited by this paper
• Chapter 32 – The Human Mucosal B-Cell System

  2005cited by this paper
• Use of adenoviral vectors as veterinary vaccines

  2005cited by this paper
• Proteolytic Processing of the Mycoplasma hyopneumoniae Cilium Adhesin

  2004cited by this paper
• Efficacy of vaccines against bacterial diseases in swine: what can we expect?

  2004cited by this paper
• Adenoviruses as vaccine vectors

  2004cited by this paper
• Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice 1

  2003cited by this paper
• Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine.

  2003cited by this paper
• Enhanced Mucosal Immunoglobulin A Response of Intranasal Adenoviral Vector Human Immunodeficiency Virus Vaccine and Localization in the Central Nervous System

  2003cited by this paper
• Expression and Immunogenicity of Mycoplasma hyopneumoniae Heat Shock Protein Antigen P42 by DNA Vaccination

  2003cited by this paper
• A Morphologic and Immunohistochemical Study of the Bronchus-associated Lymphoid Tissue of Pigs Naturally Infected with Mycoplasma hyopneumoniae

  2003cited by this paper
• Adenovirus-based libraries: efficient generation of recombinant adenoviruses by positive selection with the adenovirus protease

  2002cited by this paper
• DNA Vaccination with Genes EncodingToxoplasma gondii Antigens GRA1, GRA7, and ROP2 Induces Partially Protective Immunity against Lethal Challenge in Mice

  2000cited by this paper
• Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs.

  2000cited by this paper
• Species-Specific Monoclonal Antibodies to Escherichia coli-Expressed p36 Cytosolic Protein ofMycoplasma hyopneumoniae

  2000cited by this paper
• Cytological and immunological changes in bronchoalveolar lavage fluid and histological observation of lung lesions in pigs immunized with Mycoplasma hyopneumoniae inactivated vaccine prepared from broth culture supernate.

  2000cited by this paper
• R1 Region of P97 Mediates Adherence ofMycoplasma hyopneumoniae to Swine Cilia

  2000cited by this paper
• Adhesins as targets for vaccine development.

  1999cited by this paper
• Mycoplasma hyopneumoniae Potentiation of Porcine Reproductive and Respiratory Syndrome Virus-Induced Pneumonia

  1999cited by this paper
• Differential induction of immunoglobulin G subclasses by immunization with DNA vectors containing or lacking a signal sequence.

  1998cited by this paper
• Identification of the Cilium Binding Epitope of theMycoplasma hyopneumoniae P97 Adhesin

  1998cited by this paper
• Reiterated repeat region variability in the ciliary adhesin gene of Mycoplasma hyopneumoniae.

  1998cited by this paper
• Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.

  1997cited by this paper
• Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant.

  1997cited by this paper
• Characterization of the gene encoding Mhp1 from Mycoplasma hyopneumoniae and examination of Mhp1's vaccine potential.

  1997cited by this paper
• Swine mycoplasmoses: -EN- -FR- -ES-

  1996cited by this paper
• Restricted B-cell responses to microbial challenge of the respiratory tract.

  1996cited by this paper
• Swine mycoplasmoses.

  1996cited by this paper
• Ciliostasis and loss of cilia induced by Mycoplasma hyopneumoniae in porcine tracheal organ cultures

  1994cited by this paper
• Towards the Control of Emerging Bluetongue Disease

  1993cited by this paper
• Adherence of Mycoplasma hyopneumoniae to porcine ciliated respiratory tract cells.

  1993cited by this paper
• Serum and mucosal antibody responses against Mycoplasma hyopneumoniae following intraperitoneal vaccination and challenge of pigs with M hyopneumoniae.

  1993cited by this paper
• Protective immune response to Mycoplasma gallisepticum demonstrated in respiratory-tract washings from M. gallisepticum-infected chickens.

  1993cited by this paper
• Cloning and expression of a species-specific early immunogenic 36-kilodalton protein of Mycoplasma hyopneumoniae in Escherichia coli

  1991cited by this paper
• Identification and mapping of an immunogenic region of Mycoplasma hyopneumoniae p65 surface lipoprotein expressed in Escherichia coli from a cloned genomic fragment

  1990cited by this paper
• Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells

  1988cited by this paper
• [Adenovirus vectors].

  1986cited by this paper
• Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs

  1985cited by this paper
• The pathogenicity of Mycoplasma flocculare.

  1973cited by this paper
• The Pathogenicity of Mycoplasma Flocculare

  1973cited by this paper
• Identification and Characterization of a Mycoplasma hyopneumoniae Adhesin

  year unknowncited by this paper

• Research Progress on Immune Evasion of Mycoplasma hyopneumoniae

  2024cites this paper
• A Recombinant Chimera Vaccine Composed of LTB and Mycoplasma hyopneumoniae Antigens P97R1, mhp390 and P46 Elicits Cellular Immunologic Response in Mice

  2023cites this paper
• Oral Immunization with Attenuated Salmonella Choleraesuis Expressing the P42 and P97 Antigens Protects Mice against Mycoplasma hyopneumoniae Challenge

  2022cites this paper
• Th1 and Th17 mucosal immune responses elicited by nasally inoculation in mice with virulence factors of Mycoplasma hyopneumoniae.

  2022cites this paper
• Mycoplasma suis Alpha-Enolase Subunit Vaccine Induces an Immune Response in Experimental Animals

  2021cites this paper
• Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs

  2021cites this paper
• Protection Efficacy of the rLTB-R1 Chimera against Experimental Swine Mycoplasmal Pneumonia

  2019cites this paper
• Analysis of swine antigen-specific antibody responses to Mycoplasma hyopneumoniae infection determined by protein microarray.

  2019cites this paper
• A concise review of vaccines against Mycoplasma hyopneumoniae.

  2019cites this paper
• Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae

  2019cites this paper
• Immunoenhancement of recombinant Neisseria meningitides PorB protein on porcine circovirus type 2 and Mycoplasma hyopneumo-niae genetically engineered vaccines.

  2019cites this paper
• Update on Mycoplasma hyopneumoniae infections in pigs: Knowledge gaps for improved disease control

  2018cites this paper
• Investigation of porcine interferons as a metaphylactic intervention against classical swine fever virus

  2017cites this paper
• Development of Mycoplasma hyopneumoniae Recombinant Vaccines.

  2016cites this paper
• Improved Alum Containing Adjuvant by Vitamin A for Enhancing Immune Responses and Efficacy of Leptospira Vaccine in Hamster Model

  2016cites this paper
• Evaluation of DNA vaccines developed against Mycoplasma struthionis sp. nov. str. Ms01 in ostriches

  2016influential citation
• Immunogenicity of IMS 1113 plus soluble subunit and chimeric proteins containing Mycoplasma hyopneumoniae P97 C-terminal repeat regions.

  2014cites this paper
• Local and systemic immune responses induced by a recombinant chimeric protein containing Mycoplasma hyopneumoniae antigens fused to the B subunit of Escherichia coli heat-labile enterotoxin LTB.

  2014cites this paper
• Mycoplasma hyopneumoniae: clinical, pathological and host inflammatory responses to infection and vaccine development

  2014cites this paper
• Immune responses following vaccination of pigs and mice against Mycoplasma hyopneumoniae

  2013influential citation
• Mycoplasma hyopneumoniae: from disease to vaccine development.

  2013cites this paper
• Antibody responses induced in mice immunized with recombinant adenovectors expressing chimeric proteins of various porcine pathogens.

  2013cites this paper
• Recombinant Secreted Antigens from Mycoplasma hyopneumoniae Delivered as a Cocktail Vaccine Enhance the Immune Response of Mice

  2013cites this paper
• Recombinant secreted antigens from Mycoplasma hyopneumoniae delivered as a 1 cocktail vaccine enhance the immune response of mice 2 3 Running title : Recombinant vaccines against Mycoplasma hyopneumoniae 4 5

  2013cites this paper
• RNA interference against repulsive guidance molecule A improves axon sprout and neural function recovery of rats after MCAO/reperfusion.

  2012cites this paper
• Immunisation of mice with Mycoplasma hyopneumoniae antigens P37, P42, P46 and P95 delivered as recombinant subunit or DNA vaccines.

  2012cites this paper
• Étude de la diversité génétique d’isolats québécois de Mycoplasma hyopneumoniae provenant d’infections simples ou mixtes et caractérisation de leur sensibilité aux antimicrobiens

  2010cites this paper
• Caracterização da sinal-peptidase I de Mycoplasma hyopneumoniae

  2010cites this paper
• LS . 1 Role of nutrition and intestinal adaptation in weanling pig health

  2010cites this paper
• Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine.

  2010cites this paper
• Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector.

  2009cites this paper
• Efficient site-directed mutagenesis using an overlap extension-PCR method for expressing Mycoplasma hyopneumoniae genes in Escherichia coli.

  2009cites this paper
• Vaccination with the Mycoplasma suis recombinant adhesion protein MSG1 elicits a strong immune response but fails to induce protection in pigs.

  2009cites this paper
• Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein vaccines in mice.

  2008cites this paper
• The development of non antibiotic resistant recombinant vaccines against mycoplasma hyopneumoniae

  2008cites this paper
• Targeting the porcine immune system—Particulate vaccines in the 21st century

  2008cites this paper
• Mycoplasma hyopneumoniae infections in pigs: update on epidemiology and control

  2007cites this paper
• Control of Mycoplasma hyopneumoniae infections in pigs

  2007cites this paper